Purchase Order 75N91022P00274
- Not listed
- <p>This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency, to Sedecal Molecular Imaging SL, a foreign-owned for-profit manufacturer, for maintenance services on a SuperArgus PET/CT 2R scanner. The contract has a ceiling value of $285,000.00 and a performance period from January 1, 2021 to December 31, 2021, representing the fourth option year. The contract does not have a set-aside designation.</p>
- The National Cancer Institute at the National Institutes of Health awarded a $662,617.35 firm fixed-price purchase order to GE Precision Healthcare LLC for preventative maintenance services of a GE Healthcare Discovery MI DR positron emission tomography/computed tomography (PET/CT) scanner located at the Molecular Imaging Branch in Bethesda, Maryland. The contract was awarded on March 16, 2024, with an ultimate completion date of March 15, 2027, covering a base period and two one-year option...
- The National Cancer Institute (NCI), part of the National Institutes of Health, awarded a firm fixed-price purchase order to MR Solutions Inc. for preventive maintenance services and support of a single MRS*PET/CT imaging scanner system at its Bethesda, Maryland facility. The contract, valued at $244,510.05 with a completion date of March 31, 2028, was awarded on April 1, 2025. MR Solutions Inc., the original equipment manufacturer located in Acton, Massachusetts, will provide comprehensive...
- The National Cancer Institute (NCI), a component of the National Institutes of Health under the Department of Health and Human Services, awarded a $124,362 firm fixed-price purchase order to Gatan Inc. for preventive maintenance and pre-inspection services on specialized imaging equipment. The contract was awarded on March 6, 2026, with an ultimate completion date of March 5, 2027, and will be performed at the NCI's Bethesda, Maryland facility. This sole-source procurement, issued without...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $25,000 purchase order to Medilumine Inc., doing business as Imagerie Medilumine, for maintenance services. The one-year contract, with a period of performance from July 1, 2023 through June 30, 2024, will provide maintenance for imaging equipment located at the NIH campus in Bethesda, Maryland. A firm fixed price was established for the support. No additional details were provided...
- This is a $77,824 firm fixed price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to MR Solutions Americas, LLC for preventative maintenance services on a government-owned MR Solutions microPET/CT imaging scanner located at the NIH campus in Bethesda, Maryland. The contract has a base period of 12 months and two 12-month option periods, for a potential total duration of approximately 3 years. This is an unrestricted commercial item...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, to Mediso USA, LLC, a for-profit limited liability company. The contract is for a full-service maintenance agreement covering two (2) PET/CT scanning instruments. The total potential value of the contract is $200,000.00, with a period of performance from July 1, 2025, through June 30, 2026. The contract does not have a set-aside...
- The National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, awarded a firm fixed-price purchase order contract to Mediso Usa, LLC for preventative maintenance and service of a MEDISO MultiScan LFER 150 PET/CT (Positron Emission Tomography/Computed Tomography) imaging system. The initial period of performance commenced on May 17, 2023, and the contract structure includes multiple option years, with the ultimate completion date extending through May 16,...
- General Electric Company, doing business as GE Healthcare, was awarded a firm fixed-price purchase order valued at approximately $576,000 by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. Under the terms of the contract, GE Healthcare will provide all labor, materials, and equipment necessary to maintain and conduct preventive maintenance for a GE Discovery MI Digital Ready PET/CT clinical scanner located in...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $769,640 firm fixed price purchase order to Mediso USA LLC. Under this contract, Mediso will supply and install a NanoScan PET122S/CT1512 small animal imaging system along with accessories, discounts, and training at the prime contractor's place of performance in Rockville, Maryland. The high-sensitivity and resolution imaging equipment will support the National...
The National Cancer Institute awarded a $120,000 firm fixed-price purchase order to Sedecal Molecular Imaging SL for preventive maintenance services on a government-owned Sedecal pre-clinical BioPET/CT imaging scanner located in Bethesda, Maryland. The contract, awarded on March 1, 2022, with an ultimate completion date of February 29, 2024, supports the Institute's research infrastructure and aligns with the Department of Government Efficiency cost efficiency initiative. No set-aside designation was applied to this procurement. Sedecal Molecular Imaging SL, as the original equipment manufacturer, is positioned to provide specialized maintenance services critical to sustaining the operational capability of the BioPET/CT imaging system used in preclinical cancer research. The preventive maintenance approach helps ensure equipment reliability and extends asset life, supporting NCI's research mission within the National Institutes of Health under the Department of Health and Human Services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 3/18/26 | |
| P00001 | Exercise an Option | $60.0k | 2/16/23 | |
| Not listed | Not listed | $60.0k | 2/18/22 |